Department of Medicine, Imperial College London, London SW7 2AZ, United Kingdom.
J Biol Chem. 2013 Jan 4;288(1):332-42. doi: 10.1074/jbc.M112.393322. Epub 2012 Nov 19.
Tissue inhibitor of metalloproteinases-3 (TIMP-3) plays a key role in regulating extracellular matrix turnover by inhibiting matrix metalloproteinases (MMPs), adamalysins (ADAMs), and adamalysins with thrombospondin motifs (ADAMTSs). We demonstrate that levels of this physiologically important inhibitor can be regulated post-translationally by endocytosis. TIMP-3 was endocytosed and degraded by a number of cell types including chondrocytes, fibroblasts, and monocytes, and we found that the endocytic receptor low density lipoprotein receptor-related protein-1 (LRP-1) plays a major role in TIMP-3 internalization. However, the cellular uptake of TIMP-3 significantly slowed down after 10 h due to shedding of LRP-1 from the cell surface and formation of soluble LRP-1 (sLRP-1)-TIMP-3 complexes. Addition of TIMP-3 to HTB94 human chondrosarcoma cells increased the release of sLRP-1 fragments of 500, 215, 160, and 110 kDa into the medium in a concentration-dependent manner, and all of these fragments were able to bind to TIMP-3. TIMP-3 bound to sLRP-1, which was resistant to endocytosis, retained its inhibitory activity against metalloproteinases. Extracellular levels of sLRP-1 can thus increase the half-life of TIMP-3 in the extracellular space, controlling the bioavailability of TIMP-3 to inhibit metalloproteinases.
组织金属蛋白酶抑制剂 3(TIMP-3)通过抑制基质金属蛋白酶(MMPs)、解整合素金属蛋白酶(ADAMs)和含血栓反应蛋白基序的解整合素金属蛋白酶(ADAMTSs)在调节细胞外基质的周转中发挥关键作用。我们证明,这种具有生理重要性的抑制剂的水平可以通过内吞作用进行翻译后调节。TIMP-3 被包括软骨细胞、成纤维细胞和单核细胞在内的多种细胞类型内吞和降解,我们发现内吞受体低密度脂蛋白受体相关蛋白-1(LRP-1)在 TIMP-3 的内化中起主要作用。然而,由于细胞表面 LRP-1 的脱落和可溶性 LRP-1(sLRP-1)-TIMP-3 复合物的形成,TIMP-3 的细胞摄取在 10 小时后显著减慢。将 TIMP-3 添加到 HTB94 人软骨肉瘤细胞中,以浓度依赖的方式增加了 500、215、160 和 110 kDa 的 sLRP-1 片段进入培养基中的释放,并且所有这些片段都能够与 TIMP-3 结合。TIMP-3 与 sLRP-1 结合,sLRP-1 不能被内吞,仍然保持对金属蛋白酶的抑制活性。因此,细胞外 sLRP-1 的水平可以增加 TIMP-3 在细胞外空间的半衰期,控制 TIMP-3 抑制金属蛋白酶的生物利用度。